Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer

被引：2
作者：
Koochekpour, Shahriar [1 ,2 ]
机构：
[1] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Canc Genet, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Ctr Genet & Pharmacol, Dept Urol, Buffalo, NY 14263 USA
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2014年 / 10卷 / 06期
关键词：
CASTRATION; LANDSCAPE;
D O I：
10.7150/ijbs.9576
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：652 / 653
页数：2
相关论文
共 50 条
  • [21] Novel drugs targeting the androgen receptor pathway in prostate cancer
    Mateo, Joaquin
    Smith, Alan
    Ong, Michael
    de Bono, Johann S.
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 567 - 579
  • [22] RhoGDIα Downregulates Androgen Receptor Signaling in Prostate Cancer Cells
    Zhu, Yezi
    Liu, Chengfei
    Tummala, Ramakumar
    Nadiminty, Nagalakshmi
    Lou, Wei
    Gao, Allen C.
    PROSTATE, 2013, 73 (15) : 1614 - 1622
  • [23] Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
    Denmeade, Samuel R.
    Sena, Laura A.
    Wang, Hao
    Antonarakis, Emmanuel S.
    Markowski, Mark C.
    ONCOLOGIST, 2023, 28 (06) : 465 - 473
  • [24] Prostate cancer as a dedifferentiated organ : androgen receptor, cancer stem cells, and cancer stemness
    Liu, Xiaozhuo
    Li, Wen Jess
    Puzanov, Igor
    Goodrich, David W.
    Chatta, Gurkamal
    Tang, Dean G.
    ESSAYS IN BIOCHEMISTRY, 2022, 66 (04) : 291 - 303
  • [25] Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
    Chen, Yu
    Clegg, Nicola J.
    Scher, Howard I.
    LANCET ONCOLOGY, 2009, 10 (10) : 981 - 991
  • [26] Relationship Between Serum Response Factor and Androgen Receptor in Prostate Cancer
    Prencipe, Maria
    O'Neill, Amanda
    O'Hurley, Gillian
    Nguyen, Lan K.
    Fabre, Aurelie
    Bjartell, Anders
    Gallagher, William M.
    Morrissey, Colm
    Kay, Elaine W.
    Watson, R. William
    PROSTATE, 2015, 75 (15) : 1704 - 1717
  • [27] Reprogramming of Isocitrate Dehydrogenases Expression and Activity by the Androgen Receptor in Prostate Cancer
    Gonthier, Kevin
    Poluri, Raghavendra Tejo Karthik
    Weidmann, Cindy
    Tadros, Maude
    Audet-Walsh, Etienne
    MOLECULAR CANCER RESEARCH, 2019, 17 (08) : 1699 - 1709
  • [28] Androgen receptor-binding sites are highly mutated in prostate cancer
    Morova, Tunc
    McNeill, Daniel R.
    Lallous, Nada
    Gonen, Mehmet
    Dalal, Kush
    Wilson, David M., III
    Guersoy, Attila
    Keskin, Ozlem
    Lack, Nathan A.
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [29] Combining prostate cancer radiotherapy with therapies targeting the androgen receptor axis
    Ghashghaei, M.
    Kucharczyk, M.
    Elakshar, S.
    Muanza, T.
    Niazi, T.
    CURRENT ONCOLOGY, 2019, 26 (05) : E640 - E650
  • [30] Androgen receptor splice variants and prostate cancer: From bench to bedside
    Wadosky, Kristine M.
    Koochekpour, Shahriar
    ONCOTARGET, 2017, 8 (11) : 18550 - 18576
12345